To date, the major randomised controlled trials investigating the clinical outcomes of bariatric surgery for T2DM have focused predominantly on patients with more recent onset disease not requiring insulin, as opposed to patients with disease of longer duration requiring insulin [3,4]. The gene discussed is INS; the disease is type 2 diabetes mellitus.